Materials & Resources » Chemicals | Sumitomo Seika Chemicals Co. Ltd.

Sumitomo Seika Chemicals Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
9,809
16,417
14,622
18,931
20,212
13,979
Total Accounts Receivable
23,084
21,748
19,879
23,333
24,945
26,878
Inventories
13,066
14,120
14,736
12,035
13,456
17,329
Other Current Assets
3,695
3,242
3,180
3,260
4,103
3,198
Total Current Assets
49,654
55,527
52,417
57,562
62,718
61,385
Net Property, Plant & Equipment
40,833
44,577
47,272
42,559
42,496
39,752
Total Investments and Advances
1,224
1,337
1,014
1,423
1,630
1,445
Intangible Assets
981
433
207
322
287
219
Other Assets
668
1,747
1,845
1,820
2,046
2,175
Total Assets
95,050
104,954
104,576
105,396
110,492
105,779
ST Debt & Current Portion LT Debt
11,271
15,407
10,983
10,437
15,715
Accounts Payable
12,101
9,243
10,059
12,250
14,420
Income Tax Payable
2,817
1,229
1,525
1,991
1,560
Other Current Liabilities
3,962
6,034
3,178
3,397
5,140
Total Current Liabilities
30,151
31,913
25,745
28,075
36,835
Long-Term Debt
15,283
16,483
21,158
15,238
6,003
Provision for Risks & Charges
1,676
933
1,478
1,135
1,032
Deferred Taxes
1,616
1,273
1,756
1,644
1,269
Total Liabilities
47,184
49,389
48,446
44,510
43,914
Common Equity (Total)
46,098
53,123
53,548
58,470
64,407
Total Shareholders' Equity
46,098
53,123
53,548
58,470
64,407
Total Equity
47,866
55,565
56,130
60,884
66,576
Liabilities & Shareholders' Equity
95,050
104,954
104,576
105,394
110,490
Accumulated Minority Interest
1,768
2,442
2,582
2,414
2,169

About Sumitomo Seika Chemicals Co.

View Profile
Address
Sumitomo Building
Osaka Osaka 541
Japan
Employees -
Website http://www.sumitomoseika.co.jp
Updated 07/08/2019
Sumitomo Seika Chemicals Co., Ltd. engages in the manufacture and sale of chemical products. It operates through the following segments: Chemicals, Super Absorbent Polymers, and Gases and Engineering. The Chemicals segment provides industrial chemicals, pharmaceutical products, polymers, and functional products.